PA GOODDOCTOR (01833) surged more than 5% against the market trend, reaching HK$14.32 with a trading volume of HK$264 million by the time of writing.

The rise follows the announcement that PA GOODDOCTOR Investment Management Co., Ltd. has been selected as one of the first pilot units for high-quality workplace health management. The selection was unveiled during the "Implementing Health Priority Development Strategy and Sharing Health Management Responsibilities" national pilot project on major chronic disease prevention and innovation integration, held in Beijing from December 11-12, 2025.

The company's inclusion is attributed to its extensive experience, professional service capabilities, and comprehensive health management model covering the entire employee health lifecycle. The national project recognized PA GOODDOCTOR for its unique "finance + healthcare" integrated service approach, embodied in its corporate health strategy.

PA GOODDOCTOR's strategy focuses on transforming corporate health management in three key areas: shifting from "post-treatment claims" to "preventive care," moving from "general welfare" to "targeted interventions," and transitioning from a "cost center" to "value creation."

As part of the pilot program in East and South China, PA GOODDOCTOR will leverage its integrated online-offline healthcare network to provide seamless services, including online consultations, specialist appointments, and chronic disease management. The company will also utilize AI and big data to help enterprises build employee health profiles and disease risk prediction models, enabling precise health management.

Additionally, PA GOODDOCTOR will collaborate with pilot companies to explore innovative mechanisms linking health management outcomes with insurance costs, testing the feasibility of optimizing overall welfare investments through health behavior incentives.